Prosecutors imposed significant penalties exceeding $US8 billion against OxyContin maker Purdue Pharma, although the lion’s share will go unpaid.
Prosecutors imposed significant penalties exceeding $US8 billion against OxyContin maker Purdue Pharma, although the lion’s share will go unpaid.